Phoenixgroup Press Releases

PHOENIX group highlights patient-centric concepts at NEXT Pharma Summit


PHOENIX group highlights patient-centric concepts at NEXT Pharma Summit


Phoenix Group Logo 150x81

Press Release | PHOENIX group

MAY 20, 2019

Mannheim, Germany: – Leading European integrated healthcare provider and pharma wholesaler PHOENIX group was a high profile presence at this year’s NEXT Pharma Summit in the ancient Croatian city of Dubrovnik.

An impressive roster of pharma industry speakers included PHOENIX group´s Corporate Pharma Services Head of Marketing, Olaf Christiansen.

Bringing stakeholders together

On day one of the conference (6th May 2019) Mr. Christiansen was one of the main contributors to Track 2 on Patient Care with his presentation on ‘Bringing stakeholders together’. This provided insights and experiences drawn from Patient Centricity Programs at PHOENIX group, one of Europe´s biggest healthcare providers.

Mr. Christiansen showed how patient centric concepts were woven into the fabric of PHOENIX’s All-in-One service program with its overall focus on providing a range of solutions in which all activities were designed around patient experience and individualisation.

Patient-centric strategy

He also explained how the patient centricity concept was now driving overall PHOENIX group’s strategy across Europe, as exemplified by it being the main focus of discussion at its recent Healthcare Executive Forum.

The delivery of patient-centric services included PHOENIX adherence services, vaccination campaigns (including marketing services and healthcare education) and recent introduction of a new medication therapy management-App for oncology patients in Germany.

Adding value

“My goal at the NEXT summit was to show European healthcare leaders that there is a defined bottom line opportunity in patient centric solutions with PHOENIX group. Quite simply, if the patient gets more targeted and responsive care, that represents an added value for all parties, driving both better patient outcomes and increased sales.”, said Olaf Christiansen.

Dr. Alexander Maier, PHOENIX group´s Corporate Pharma Services Head of Service Development was also present in Dubrovnik and both he and Mr. Christiansen engaged in productive discussions with representatives from the healthcare and pharma industries across Europe.

About PHOENIX group

The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical trader in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 36,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.

The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering. In pharmaceutical wholesale, the PHOENIX group is active with 164 distribution centers in 27 countries and supplies pharmacies and medical institutions with drugs and other health products. Numerous other products and services for pharmacy customers complete the portfolio – from assistance in advising patients to modern goods management systems to pharmacy cooperation programmes. With around 13,500 member pharmacies, PHOENIX Pharmacy Partnership is the umbrella for our European network of 13 cooperation and partner programmes in 16 countries. Pharma Services provides services across the whole supply chain for the pharmaceutical industry. The PHOENIX group already operates around 2,500 of its own pharmacies in 14 European countries, thereby having profound knowledge of the pharmacy business. Our approximately 18,500 pharmacy employees have around 140 million customer contacts each year. They dispense approximately 315 million drug packages to patients and advise them on issues concerning pharmaceuticals and general health.

Further information about the PHOENIX group | www.phoenix-all-in-one.eu.

About NEXT Pharma Summit 2019

The annual NEXT Pharma Summit focuses on pharma commercial and medical issues, gathering together pharma executives, global healthcare heads and solution vendors to ask a simple question: Where to NEXT?

The 2019 NEXT summit was a two-day event, opening 6 May at Dubrovnik’s Hotel Valamar Lacroma, overlooking the Adriatic Sea. It featured three tracks on separate stages:

The summit attracted more than 300 delegates to hear more than 40 speakers, including keynotes from Davidek Herron, Teva’s Head of Outbound Digital Channels, Europe & International Markets, Harout Semerjian, Ipsen’s EVP & Chief Commercial Officer, Shwen Gwee, Head of Open Innovation at Novartis, Christopher Boone, Pfizer Vice President heading its Analytics Center of Excellence, Emmanuel Fombu, head of Global Commercial Strategy and Digital Innovation at Johnson & Johnson and Dr. Gabriel Morelli, Global Head of Commercial Excellence at Sandoz International.

The event is organised by Croatia-based a2 Tech, with further information at: https://nextpharmasummit.com.

Media Contact

Olaf Christiansen, Head of Marketing, PHOENIX group
Tel: +49 621 8505-8217
Email: o.christiansen@phoenixgroup.eu

Resources

Click on PHOENIX at NEXT Pharma 2019 for other information.
Click on PHOENIX group to contact the company directly.
Click on Meet PHOENIX for further information on the group’s events programme.

Phoenix

Phoenix 1

Phoenix 3


Supplier Information
Supplier: PHOENIX group
Address: Pfingstweidstraße 10-12, 68199 Mannheim, Germany
Tel: +49 621 8505-8217
Website: www.phoenix-all-in-one.eu


PHOENIX group Finnish subsidiary Medaffcon pioneers biobank research


PHOENIX group Finnish subsidiary Medaffcon pioneers biobank research


Phoenix Group Logo 150x81

Press Release | PHOENIX group

APRIL 12, 2019

Espoo, Finland: – Medaffcon Oy, the Finnish arm of leading European integrated healthcare provider and pharma wholesaler PHOENIX group, is taking pioneering steps in utilising biobanks for research and real-world evidence (RWE) generation. Biobank research and RWE are increasingly used by the pharmaceutical industry for a broad spectrum of purposes, ranging from preclinical studies accelerating drug development to post-approval studies evaluating the clinical effectiveness of products during everyday clinical practice.

Medaffcon, part of the PHOENIX group, is an ESPOO based company providing medical and health economic expertise. Medaffcon is the leading private-sector RWE provider in Finland and has been conducting biobank research since the establishment of the first biobanks in the country. To date, Medaffcon has carried out dozens of biobank studies in various research settings, promoting patient-centric and effective healthcare.

To showcase the activity and unique research opportunities offered by the Finnish hospital biobanks, Medaffcon has recently, in collaboration with the University of Eastern Finland, assessed the operational status and sample availability in the six regional biobanks. Special emphasis was put to define possibilities of the hospital biobanks to support the needs of international pharma and health technology companies. Outcome of the survey has been compiled in a report format (see Resources).

World-class research opportunities

Setting up a nation-wide biobank infrastructure that supports innovative approaches to study diseases and promote health and wellbeing has been an integral part of Finland’s Health Sector Growth Strategy for Research and Innovation Activities. To date, the Finnish biobank infrastructure consists of ten biobanks along with the legislation that supports the collection of samples and, with a broad consent, use of them for various research purposes.

The report by Medaffcon describes how the six hospital biobanks, that currently store over 11 million diagnostic samples gathered from around three million individuals have created an internationally unique research infrastructure in Finland. Since the establishment of the first Finnish biobanks 2014 onwards, the number of biobank studies have increased at an accelerating pace. By the end of May 2018 there were close to 200 studies initiated that utilize samples and data collections at the Finnish hospital biobanks, including study initiators from both public (62%) and private (38%) sector.

For more information and examples on the vast RWE opportunities provided by the Finnish biobanks to the global pharmaceutical industry, visit Future Care Finland platform (see resources), a website developed and maintained by Medaffcon.

Accelerating progress

In addition to retrospective samples, collected before the Biobank Act took effect, all hospital biobanks are actively gathering new prospective samples from consenting people. By May 2018, close to 80,000 new samples had been collected. Along with the new sample collections, support from the hospital districts and expanding availability of genome information, the pace of initiating new biobank studies is expected to rise quickly over the coming years.

Medaffcon proactively promotes the biobank research opportunities in Finland as detailed in the current issue of the magazine Biobanking in Finland & Personalized Medicine, viewable online (see Resources). While there are several biobanks in Europe, Finnish biobanking landscape stands out due to several unique features. These include Finland’s universal healthcare that provides a ground for unbiased data with excellent population coverage, use of the national id -system that allows linkage of data between different sources, such as national and disease-specific registries, as well as governmental support and legislation that enables the use of health data for research purposes. For these reasons Finland is a forerunner in biobanking activities also internationally.

“We at Medaffcon see that Finnish biobanks offer enormous opportunities for the international pharma industry. We are excited to be part of this development and want to use our expertise in providing innovative solutions that advance healthcare and wellbeing of future patients”.

About PHOENIX group

The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical trader in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 36,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.

The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering. In pharmaceutical wholesale, the PHOENIX group is active with 164 distribution centers in 27 countries and supplies pharmacies and medical institutions with drugs and other health products. Numerous other products and services for pharmacy customers complete the portfolio – from assistance in advising patients to modern goods management systems to pharmacy cooperation programmes. With around 13,500 member pharmacies, PHOENIX Pharmacy Partnership is the umbrella for our European network of 13 cooperation and partner programmes in 16 countries. Pharma Services provides services across the whole supply chain for the pharmaceutical industry.

The PHOENIX group already operates around 2,500 of its own pharmacies in 14 European countries, thereby having profound knowledge of the pharmacy business. Our approximately 18,500 pharmacy employees have around 140 million customer contacts each year. They dispense approximately 315 million drug packages to patients and advise them on issues concerning pharmaceuticals and general health.
Further information about the PHOENIX group | www.phoenix-all-in-one.eu.

Media Contact

Olaf Christiansen, Head of Marketing, PHOENIX group
Tel: +49 621 8505-8217
Email: o.christiansen@phoenixgroup.eu

Resources

Click on PHOENIX Medaffcon supports biobanking for other information.
Click on PHOENIX group to contact the company directly.
Click on Finland & Personalized Medicine Magazine to read digital edition.
Click on Future Care Finland Article for overview of Finnish hospital biobanking.
Click on Current operational status of the Finnish hospital biobanks to download the Medaffcon report.

Finland’s six registered, operational hospital biobanks  operate in determined healthcare regions. This map indicates demographic locations of the hospital biobanks, population coverage and the timepoints of seeking consent and sample gathering.

Finland’s six registered, operational hospital biobanks operate in determined healthcare regions. This map indicates demographic locations of the hospital biobanks, population coverage and the timepoints of seeking consent and sample gathering


Supplier Information
Supplier: PHOENIX group
Address: Pfingstweidstraße 10-12, 68199 Mannheim, Germany
Tel: +49 621 8505-8217
Website: www.phoenix-all-in-one.eu


PHOENIX group presenting integrated solutions at LogiPharma Montreux


PHOENIX group presenting integrated solutions at LogiPharma Montreux


Phoenix Group Logo 150x81

Press Release | PHOENIX group

MARCH 29, 2019

Mannheim, Germany: – Leading European integrated healthcare provider PHOENIX group will be a high profile presence at this year’s LogiPharma forum in Switzerland.

PHOENIX will be an exhibitor at the event with a stand at Booth 48 in the expo area at the Montreux Music & Convention Center. The PHOENIX display will focus on its All-in-One service brand, together with healthcare logistics (HCL) solutions and especially regional solutions such as its central European (CEE) Bridge network.

Overcoming Balkan complexities

It will also host a MasterClass on ‘Solutions for a complex region: Healthcare Logistics for all Non-EU Balkan countries’, led by Marija Petrovic, Regional Director Pharma Service and Business Development for PHOENIX Serbia.

The session will show how PHOENIX can help to overcome the physical borders and locally specific regulations that can add more than 30 days to logistics lead times, based on experience from servicing more than 30 clients already using its Belgrade HUB and CEE Bridge network.

The PHOENIX group team in Montreux will include also European Key Account Managers Annikki Vuola and Dr. Zoltan Kelemen.

Integrated healthcare solutions

“LogiPharma 2019 provides us with an excellent platform to showcase our complex and comprehensive Healthcare Logistics solutions for all Non-EU Balkan countries,” commented Dr. Kelemen.

“We aim to use the event to raise attention to our strong and unique presence in the Balkan region, where PHOENIX has the key with the Balkan pillar of our international CEE Bridge network including our state-of-the-art HUB in Belgrade,” said Dr. Kelemen.

“We will also demonstrate the potential of our integrated healthcare All-in-One services in providing tailor-made solutions for individual client and patient needs,” he added.

About PHOENIX group

The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical distributor and trading corporation in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare services with more than 36,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.

The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering. In pharmaceutical wholesale, the PHOENIX group is active with 164 distribution centers in 27 countries and supplies pharmacies and medical institutions with drugs and other health products. Numerous other products and services for pharmacy customers complete the portfolio – from assistance in advising patients to modern goods management systems to pharmacy cooperation programmes. With around 13,500 member pharmacies, PHOENIX Pharmacy Partnership is the umbrella for our European network of 13 cooperation and partner programmes in 16 countries. Pharma Services provides services across the whole supply chain for the pharmaceutical industry. The PHOENIX group already operates around 2,500 of its own pharmacies in 14 European countries, thereby having profound knowledge of the pharmacy business. Our approximately 18,500 pharmacy employees have around 140 million customer contacts each year. They dispense approximately 315 million drug packages to patients and advise them on issues concerning pharmaceuticals and general health.

Further information about the PHOENIX group | www.phoenixgroup.eu

About LogiPharma 2019

The LogiPharma meeting provides an annual networking and thought leadership platform for decision makers in pharma supply chain, logistics, distribution, planning, IT, quality and sourcing to meet and shape the future of their industry.

LogiPharma 2019 is a three-day event, opening 9th April, returning to the Montreux Music & Convention Centre, Switzerland. It will feature some 80 speakers representing supply chain players and leading pharmaceutical manufacturers.

The event is expected to attract more than 850 delegates and feature some 80 keynote speakers. The key theme for the 2019 event will be ‘Building Digitally Connected Pharma Supply Chain Networks’.

The event is organised by WB Research with more information at: https://LogiPharmaeu.wbresearch.com/

Media Contact

Olaf Christiansen, Head of Marketing, PHOENIX group
Tel: +49 621 8505-8217
Email: o.christiansen@phoenixgroup.eu

Resources

Click on PHOENIX at LogiPharma 2019 for other information.
Click on PHOENIX group to contact the company directly.
Click on Meet PHOENIX for further information on the group’s events programme.


Supplier Information
Supplier: PHOENIX group
Address: Pfingstweidstraße 10-12, 68199 Mannheim, Germany
Tel: +49 621 8505-8217
Website: www.phoenix-all-in-one.eu


PHOENIX group outlining patient-centric future at BGF Munich


PHOENIX group outlining patient-centric future at BGF Munich


Phoenix Group Logo 150x81

Press Release | PHOENIX group

MARCH 22, 2019

Mannheim, Germany: – Leading European integrated healthcare provider PHOENIX group will make meaningful contributions to the 2019 Bavarian Healthcare Forum (BGF Gesundheitsforum) in Munich.

PHOENIX Head of Corporate Pharma Services & Sourcing Stefan Jung will be one of the panellists in the discussion session ‘Beyond the Pill’ exploring holistic and individualised healthcare solutions that will take place on day one of the congress.

Patient centricity

Mr. Jung will highlight the potential for genuinely patient-centric services that go beyond mere pharmaceuticals, which PHOENIX is helping to deliver across Europe via its All-in-One Service brand.

The PHOENIX team at the BGF congress will also include Olaf Christiansen, Dr. Alexander Maier from PHOENIX group as well as Dr. Katja Acker and Annette Müller from PHOENIX Germany.

“As a truly integrated healthcare provider, PHOENIX group’s All-in-One services can provide tailor-made solutions for patients’ individual needs,” commented Stefan Jung.

Adding value

“We have moved beyond acting merely as a wholesaler of supplies to become the best integrated healthcare provider in Europe, with a Pharma Services division that combines the whole range of value-adding services for the industry, including business intelligence solutions and patient services in the form of pharmacy adherence programs,” Mr. Jung explained.

“As a result, patients throughout Europe benefit not only from our secure delivery to pharmacies, but also from the important information they receive about pharmacies thanks to us,” he added.

About PHOENIX group

The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical trader in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 36,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.

The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering. In pharmaceutical wholesale, the PHOENIX group is active with 164 distribution centers in 27 countries and supplies pharmacies and medical institutions with drugs and other health products. Numerous other products and services for pharmacy customers complete the portfolio – from assistance in advising patients to modern goods management systems to pharmacy cooperation programmes. With around 13,500 member pharmacies, PHOENIX Pharmacy Partnership is the umbrella for our European network of 13 cooperation and partner programmes in 16 countries. Pharma Services provides services across the whole supply chain for the pharmaceutical industry. The PHOENIX group already operates around 2,500 of its own pharmacies in 14 European countries, thereby having profound knowledge of the pharmacy business. Our approximately 18,500 pharmacy employees have around 140 million customer contacts each year. They dispense approximately 315 million drug packages to patients and advise them on issues concerning pharmaceuticals and general health.

Further information about the PHOENIX group | www.phoenixgroup.eu

About BGF 2019

Originally founded as the Coburg Health Forum, the Bayerisches Gesundheitsforum (Bavarian Health Forum) has been an integral part of the European healthcare world for close to two decades.

Dedicated to examining the workings and improvement of healthcare markets as well as leading-edge trends in therapy and life sciences, the forum brings together close to 100 expert speakers in a series of focused topic discussion sessions.

BGF 2019 is a two-day event, opening 5th April at the Leonardo Royal Hotel, Munich.

The event is organised by the Bayerisches Gesundheits Management (BGM) with further information available at: More information at: https://www.bgm.ag/kongress/bgf-gesundheitsforum-2019/

Media Contact

Olaf Christiansen, Head of Marketing, PHOENIX group
Tel: +49 621 8505-8217
Email: o.christiansen@phoenixgroup.eu

Resources

Click on PHOENIX at BGF 2019 for other information.
Click on PHOENIX group to contact the company directly.
Click on Meet PHOENIX for further information on the group’s events programme.


Supplier Information
Supplier: PHOENIX group
Address: Pfingstweidstraße 10-12, 68199 Mannheim, Germany
Tel: +49 621 8505-8217
Website: www.phoenix-all-in-one.eu


PHOENIX group joins forces with Farmexim for PHARM Connect Budapest


PHOENIX group joins forces with Farmexim for PHARM Connect Budapest


Phoenix Group Logo 150x81

Press Release | PHOENIX group

MARCH 05, 2019

Mannheim, Germany: – Leading European integrated healthcare provider PHOENIX group, along with its new Romanian subsidiary Farmexim, will be high profile presences at the 2019 PHARM Connect Congress in Budapest.

The annual Budapest congress has become recognised as the foremost pharmaceutical and biotechnology business summit for Central and Eastern Europe and the CIS regions.

Stronger in Europe

PHOENIX group will be represented at the congress by its European Key Account Manager, Dr. Zoltan Kelemen and Andi Drăniceanu, Logistics Director at Farmexim.

“By entering Romania, PHOENIX group has significantly strengthened its presence and coverage in Europe. Joining forces with Farmexim was a strategic move that opened new opportunities for development in Romania, an important market in South-Central Europe,” noted Andi Drăniceanu.

All-in-One advantages

PHOENIX and Farmexim will use the congress to jointly present advantages of the All-in-One logistics and service offering, providing tailor-made solutions for any specific individual client needs.

Dr. Kelemen commented: “As a leading healthcare provider in Europe, providing drugs and medical products to patients all over Europe, our customers and partners would expect PHOENIX group to be present in Budapest for this important congress.”

Healthcare logistics partner

“Pharmaceutical wholesale is our core business but now we have added a reliable Healthcare Logistics offer that combines pre-wholesale logistics and related value-adding services delivered from more than 40 distribution centres in 23 countries,” said Dr. Kelemen.

“We will be showing delegates in Budapest how PHOENIX group can be a valuable partner for pan-European distribution, with annual capacity of more than 330,000 pallets, full logistic services in all product groups, GDP compliant international transport solutions, business intelligence solutions based on modern and flexible reporting tools and value-adding services based on the requirements of our customers,” he added.

“With our regional approaches we can offer international solutions all over Europe with our CEE Bridge network in Central and Eastern Europe, and now including Romania, with HUBs in Poland, Czech Republic and Serbia, Baltics, Nordics, Benelux and Balkans serving EU and non-EU countries alike,” Dr. Kelemen concluded.

About PHOENIX group

The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical trader in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 36,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.

The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering. In pharmaceutical wholesale, the PHOENIX group is active with 164 distribution centers in 27 countries and supplies pharmacies and medical institutions with drugs and other health products. Numerous other products and services for pharmacy customers complete the portfolio – from assistance in advising patients to modern goods management systems to pharmacy cooperation programmes. With around 13,500 member pharmacies, PHOENIX Pharmacy Partnership is the umbrella for our European network of 13 cooperation and partner programmes in 16 countries. Pharma Services provides services across the whole supply chain for the pharmaceutical industry. The PHOENIX group already operates around 2,500 of its own pharmacies in 14 European countries, thereby having profound knowledge of the pharmacy business. Our approximately 18,500 pharmacy employees have around 140 million customer contacts each year. They dispense approximately 315 million drug packages to patients and advise them on issues concerning pharmaceuticals and general health.

Further information about the PHOENIX group | www.phoenixgroup.eu

About PHARM Connect Budapest

PHARM Connect Budapest is the largest and most important pharmaceutical and biotechnology business summit for Central Eastern Europe and the CIS region, attracting more than 500 attendees from some 20 countries.

The 9th annual PHARM Connect Congress is a two-day event opening on 12th March at the Budapest Congress Centre.

The congress caters for leading service providers of the pharmaceutical and biotechnology sector – covering a wide range of profiles from API’s and contract manufacturing to logistics, cold chain storage and distribution.

More information at: http://www.pharmconnect.eu

Media Contact

Olaf Christiansen, Head of Marketing, PHOENIX group
Tel: +49 621 8505-8217
Email: o.christiansen@phoenixgroup.eu

Resources

Click on PHOENIX at PHARM Connect 2019 for other information.
Click on PHOENIX group to contact the company directly.
Click on Meet PHOENIX for further information on the group’s events programme.

Budapest Congress Centre

Budapest Congress Centre


Supplier Information
Supplier: PHOENIX group
Address: Pfingstweidstraße 10-12, 68199 Mannheim, Germany
Tel: +49 621 8505-8217
Website: www.phoenix-all-in-one.eu


PHOENIX group and INSIGHT Health invited for the first HEALTHCARE EXECUTIVE FORUM


PHOENIX group and INSIGHT Health invited for the first HEALTHCARE EXECUTIVE FORUM


Phoenix Group Logo 150x81

Press Release | PHOENIX group

MARCH 04, 2019

Mannheim, Germany: – Leading European integrated healthcare provider PHOENIX group has partnered with data provider INSIGHT Health to host the first Healthcare Executive Forum (HCEF) in Deidesheim, Germany.

The HCEF provided the basis for a select group of healthcare leaders to focus on ‘Patient Centricity in the Digital Age’ and the potential for new technology to prove more individual and tailored services for patients.

Improved patient experience

The two-day event on 24th and 25th January took place at an old winery in Deidesheim. Several executives from industry partners were invited by PHOENIX group and INSIGHT Health to hold a series of focused debates on possible future programmes to improve service, individual therapies and patient experience across Europe.

The event kicked off with a wine cellar tour followed by a gala dinner.

In the keynote speech given by Dr Angela Coulter, a UK-based research scientist from Oxford University with focus on patient and public involvement, the diverse opportunities in engaging with patients more directly within the Digital Age were discussed. Dr Coulter is internationally recognised as an influential health policy analyst and researcher in the field of patient centricity.

Future challenges

As part of its All-in-One Services, PHOENIX group already provides individual solutions for client specific needs by leveraging IT and data to improve delivery and end user experience.

Representatives from the PHOENIX group and INSIGHT Health shared their own insights on future challenges with the participants.

“To me, the most important aim was to talk in a very pragmatic way about how to put patient adherence into practice,” said PHOENIX group board member Frank Große-Natrop.

“PHOENIX is offering a lot of services that hinge on this challenge and I am really looking forward to finding solutions on behalf of our patients,” he added.

Innovative digitalised solutions

The PHOENIX group presentation was delivered by Nemanja Janković, Head of Commercial Partnerships Europe and Stefan Jung, Head of Corporate Pharma Services & Sourcing.

Stefan Jung commented: “The challenge for us as healthcare professionals is to come up with innovative solutions for patients and be more proactive in this area using all of our modern digitalisation tools.”

Jan Tangermann, Head Sales & Commercial Excellence at Sandoz was one of those invited to the event. He commented: “I am a strong believer that in our digital environment we need to engage in connecting the dots even better than we are currently doing and drive partnerships. In this complex environment partnerships are crucial, and this event allows us take our partnerships to the next level.”

About PHOENIX group

The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical trader in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 36,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.

The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering. In pharmaceutical wholesale, the PHOENIX group is active with 164 distribution centers in 27 countries and supplies pharmacies and medical institutions with drugs and other health products. Numerous other products and services for pharmacy customers complete the portfolio – from assistance in advising patients to modern goods management systems to pharmacy cooperation programmes. With around 13,500 member pharmacies, PHOENIX Pharmacy Partnership is the umbrella for our European network of 13 cooperation and partner programmes in 16 countries. Pharma Services provides services across the whole supply chain for the pharmaceutical industry. The PHOENIX group already operates around 2,500 of its own pharmacies in 14 European countries, thereby having profound knowledge of the pharmacy business. Our approximately 18,500 pharmacy employees have around 140 million customer contacts each year. They dispense approximately 315 million drug packages to patients and advise them on issues concerning pharmaceuticals and general health.

Further information about the PHOENIX group | www.phoenixgroup.eu

About INSIGHT Health

Founded in 1999, INSIGHT Health GmbH has a 20-year history of providing innovative and dynamic information services to the healthcare market. It supports customers with a broad portfolio of data-based services for market and nursing research, applicable not only to pharmaceutical manufacturers but also health insurance companies, pharmacies, medical associations as well as scientific and political health care institutions.

The company’s mission is to process healthcare data with the greatest reliability and provide added-value analyses for all participants in the health care market.

INSIGHT Health offers innovative and relevant solutions for market research, sales force effectiveness, targeting, new product launches, care and therapy, market access and business development.

Headquartered at Waldems-Esch, near Frankfurt am Main, INSIGHT Health also has branch offices in Berlin, Vienna and Baar, Switzerland.

Media Contact

Olaf Christiansen, Head of Marketing, PHOENIX group
Tel: +49 621 8505-8217
Email: o.christiansen@phoenixgroup.eu

Resources

Click on PHOENIX & INSIGHT HEALTHCARE EXECUTIVE FORUM for other information.
Click on PHOENIX group to contact the company directly.
Click on HCEF Video to view video from the event.

Phoenix Image

Supplier Information
Supplier: PHOENIX group
Address: Pfingstweidstraße 10-12, 68199 Mannheim, Germany
Tel: +49 621 8505-8217
Website: www.phoenix-all-in-one.eu


PHOENIX group headed for CTSE Europe Milan


PHOENIX group headed for CTSE Europe Milan


Phoenix Group Logo 150x81

Press Release | PHOENIX group

FEBRUARY 28, 2019

Mannheim, Germany: – Leading European integrated healthcare provider PHOENIX group will be a high-profile presence at the upcoming Clinical Trial Supply & Temperature Maintenance of Biopharmaceuticals Europe conference (CTSE 2019) in Milan.

This marks a return to Milan for PHOENIX group, which has been a consistent exhibitor at previous CTSE events to strengthen its position as Service Provider for Clinical Trial Supply Services.

The PHOENIX group stand at booth 42 will showcase the wide range of its integrated healthcare and distribution portfolio.

All-in-One offer

Offerings on display will include the tailored PHOENIX Clinical Trial Supply Services and the distinctive All-in-One offering that provides individual solutions for individual needs.

PHOENIX group will show clinical trials professionals how it is able to facilitate unparalleled access to all kind of comparator drugs, supported by its extensive network of fully-owned clinical trial depots across Europe, including Central and Eastern Europe.

Further information on the PHOENIX Clinical Trial Supply Services: https://www.phoenix-all-in-one.eu/en/benefits-best-practice/clinical-trial-supply-services/.

About PHOENIX group

The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical trader in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 36,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.

The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering. In pharmaceutical wholesale, the PHOENIX group is active with 164 distribution centers in 27 countries and supplies pharmacies and medical institutions with drugs and other health products. Numerous other products and services for pharmacy customers complete the portfolio – from assistance in advising patients to modern goods management systems to pharmacy cooperation programmes. With around 13,500 member pharmacies, PHOENIX Pharmacy Partnership is the umbrella for our European network of 13 cooperation and partner programmes in 16 countries. Pharma Services provides services across the whole supply chain for the pharmaceutical industry. The PHOENIX group already operates around 2,500 of its own pharmacies in 14 European countries, thereby having profound knowledge of the pharmacy business. Our approximately 18,500 pharmacy employees have around 140 million customer contacts each year. They dispense approximately 315 million drug packages to patients and advise them on issues concerning pharmaceuticals and general health.

Further information about the PHOENIX group | www.phoenixgroup.eu.

About CTSE 2019

The 20th Clinical Trial Supply & Temperature Maintenance of Biopharmaceuticals Europe conference (CTSE 2019) aims to help trial sponsors and solution providers across Europe to speed clinical trials delivery, improve partnerships and resolve supply chain uncertainties.

Returning to Milan, CTSE 2019 is a two-day event, opening March 13 at the international convention complex in the city center.

The 2019 conference will focus on issues including e-labelling in expediting packaging and labelling timelines, harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain and potential blockchain powered solutions.

The event is organized by Arena International with further information at: http://www.arena-international.com/ctseurope/.

Media Contact

Olaf Christiansen, Head of Marketing, PHOENIX group
Tel: +49 621 8505-8217
Email: o.christiansen@phoenixgroup.eu

Resources

Click on PHOENIX at CTSE 2019 for other information.
Click on PHOENIX group to contact the company directly.
Click on Meet PHOENIX for further information on the group’s events programme.


Supplier Information
Supplier: PHOENIX group
Address: Pfingstweidstraße 10-12, 68199 Mannheim, Germany
Tel: +49 621 8505-8217
Website: www.phoenix-all-in-one.eu


First PHOENIX-Zentiva Partnership Meeting held in Prague


First PHOENIX-Zentiva Partnership Meeting held in Prague


Phoenix Group Logo 150x81

Press Release | PHOENIX group

FEBRUARY 06, 2019

Mannheim, Germany: – Leading European integrated healthcare provider and pharma wholesaler PHOENIX group and its new partner Zentiva have staged a Partnership Meeting in Prague.

The Partnership Meeting, involving more than 40 participants from 13 countries across Central and Eastern Europe was held over two days to discuss shared plans and activities. The partnership has already embarked on its first joint project in Hungary.

Shared European activities

The Prague meeting was intended to allow partners to learn more about the new Zentiva setup, joint European activities and discuss individual country plans for 2019.

The first projects to commence under the strategic partnership are being rolled out in certain Central & Eastern European (CEE) markets. The companies will also be working at a strategic partnership level on commercial opportunities to provide better access to Zentiva products for patients across the whole of Europe.

Hungarian project

The meeting was hosted by Nemanja Jankovic, Head of Partnerships at PHOENIX group, and Robert Storch, Trade & Revenue Head at Zentiva. They updated participants about both companies’ plans and future collaboration projects.

The meeting was also briefed about progress of the PHOENIX and Zentiva teams working together in creating new jointly-provided services for Hungarian pharmacies.

On day two, all 13 country teams presented fully formed plans for the coming year to formally launch the PHOENIX-Zentiva European Partnership.

European partnership

“The friendly and trustful atmosphere at the meeting confirmed that Zentiva is the ideal partner of choice for PHOENIX, based on the company’s history, broad portfolio and presence in many European markets,” commented Nemanja Jankovic.

“The partnership between Zentiva and PHOENIX is a great match, not only because we are operating in the same industry, but also because Europe is OUR homeland,” said Robert Storch for Zentiva.

About PHOENIX group

Further information about the PHOENIX group | www.phoenixgroup.eu

The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical trader in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 36,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.

The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering. In pharmaceutical wholesale, the PHOENIX group is active with 164 distribution centres in 27 countries and supplies pharmacies and medical institutions with drugs and other health products. Numerous other products and services for pharmacy customers complete the portfolio – from assistance in advising patients to modern goods management systems to pharmacy cooperation programmes. With around 13,500 member pharmacies, PHOENIX Pharmacy Partnership is the umbrella for our European network of 13 cooperation and partner programmes in 16 countries. Pharma Services provides services across the whole supply chain for the pharmaceutical industry. The PHOENIX group already operates around 2,500 of its own pharmacies in 14 European countries, thereby having profound knowledge of the pharmacy business. Our approximately 18,500 pharmacy employees have around 140 million customer contacts each year. They dispense approximately 315 million drug packages to patients and advise them on issues concerning pharmaceuticals and general health.

About Zentiva

About Zentiva | www.zentiva.com

At Zentiva we aspire that healthcare should be a right and not a privilege. More than ever, people need better access to healthcare. Today, the everyday solutions that we all depend on truly count as a vital foundation of healthy living.

Zentiva works for the people living in Europe. Standing side-by-side with healthcare professionals, pharmacists and Health System decision-makers, we have the same sense of social obligation to help lower costs and improve access to healthcare. With more than 2,500 people across Europe and 2 production sites in Prague and Bucharest we strive to be the champions of Generics and OTC medicines to better support people’s daily healthcare needs.

Media Contact

Olaf Christiansen, Head of Marketing, PHOENIX group
Tel: +49 621 8505-8217
Email: o.christiansen@phoenixgroup.eu

Resources

Click on PHOENIX group holds Partnership Meeting with Zentiva for other information.
Click on PHOENIX group to contact the company directly.
Click on Prague Meeting to view the video from the event.

Nemanja Jankovic, Head of Partnerships at PHOENIX group (L) and Robert Storch, Trade & Revenue Head at Zentiva (R) at Prague Partnership Meeting

Nemanja Jankovic, Head of Partnerships at PHOENIX group (L) and Robert Storch, Trade & Revenue Head at Zentiva (R) at Prague Partnership Meeting


Supplier Information
Supplier: PHOENIX group
Address: Pfingstweidstraße 10-12, 68199 Mannheim, Germany
Tel: +49 621 8505-8217
Website: www.phoenix-all-in-one.eu